Exscalate4Cov: Raloxifene against Covid-19
Last June, Exscalate4Cov, the private-public consortium supported by EU's Horizon 2020 program for research and innovation, has announced an important result achieved with raloxifene.
By the in silico test, the consortium, consisted of Associazione Big Data and other 17 partners coordinated by Dompè Farmaceutici, has already tested 400.000 molecules made available by Dompè Farmaceutici and Fraunhofer Institute.
In the first part, during the virtual test, the priority was given to molecules actually on the market and considered as "safe in man".